Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion Ralph Lauren Reports Third Quarter Fiscal 2022 Results and Raises Fiscal 2022 Outlook
All Regions Reported Double-Digit Revenue Growth in the Third Quarter, Ahead of Expectations, and Positive…
MoneyLion to Present at the 23rd Annual Credit Suisse Financial Services Forum on Thursday, February 17, 2022
NEW YORK–(BUSINESS WIRE)–MoneyLion Inc. (“MoneyLion”) (NYSE:ML), the award-winning digital financial platform, announced today that Co-Founder…
Novus Capital Corporation II Reminds Stockholders to Vote in Favor of the Proposed Business Combination With Energy Vault Before February 9, 2022
INDIANAPOLIS & WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–Novus Capital Corporation II (NYSE: NXU, NXU WS and NXU.U)…
2022 Canada ALG Residual Value Awards Dominated by Toyota Canada Inc. and GM Canada, J.D. Power Finds
Toyota (Mass Market) and Lexus (Premium) Win Brand Awards TORONTO–(BUSINESS WIRE)–ALG, the division of J.D….
Wireless Providers Learning to Adapt to Evolving Customer Needs and Expectations, J.D. Power Finds
T-Mobile, Cricket and Consumer Cellular Rank Highest in Respective Segments TROY, Mich.–(BUSINESS WIRE)–Satisfaction with wireless…
Fairway Independent Mortgage Named #1 Workplace in the U.S.
MADISON, Wis.–(BUSINESS WIRE)–#mortgage—Fairway Independent Mortgage Corporation, a top-ten nationwide mortgage lender, announced that it won…
The Value of Austin’s Housing Market Surged Nearly 40% in the Past Year—Twice as Fast as the U.S.
The total value of U.S. homes soared 19% year over year to $39 trillion in…
Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results
Per Share Net Income of $0.34 and Normalized FFO of $0.47 in Fourth Quarter Robust…
BlazeMeter by Perforce Revolutionizes Testing with Built-in Test Data Generation
Latest BlazeMeter release accelerates testing and quickly creates test data for functional, performance, and virtual…
Infovista launches 360° Assurance solutions to deliver predictive, real-time and ubiquitous customer experience assurance across any operator’s entire network
Customer experience driven solutions deliver proactive service management and pre-integrated use-case based assurance solutions for…
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
NEW YORK and SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq:…
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Feb. 03, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
Freeline Appoints Henning R. Stennicke, PhD, as Chief Scientific Officer to Lead Research and Discovery
Stennicke, an industry veteran, will join Freeline to lead the research and advancement of the…
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
Collaboration focused on discovering novel ADCs for three targets by leveraging Mersana’s ADC expertise and…
Trevena to Present at the 2022 BIO CEO & Investor Conference
CHESTERBROOK, Pa., Feb. 03, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company…
ProMIS Neurosciences Appoints Renowned Neuroscientists, Dr. Guy Rouleau and Dr. Alain Dagher to its Scientific Advisory Board
TORONTO, Ontario and CAMBRIDGE, Mass. , Feb. 03, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc….
Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager Therapeutics’ Board of Directors and Newly Formed Executive Committee
Al Sandrock Al Sandrock, Executive Committee Member at Voyager Therapeutics TRACER Capsid Discovery Platform TRACER…
Pardes Biosciences Announces FDA Clearance of IND Application for PBI-0451, an Oral Antiviral Drug Candidate for the Treatment and Prevention of SARS-CoV-2 Infections
CARLSBAD, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
WALTHAM, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology…
ImCheck Announces First Patients Dosed in Phase II of EVICTION Trial for ICT01
ImCheck Announces First Patients Dosedin Phase II of EVICTION Trial for ICT01 EVICTION trial…